Literature DB >> 10798118

Melas syndrome.

S K Singh1, D Sarin, J M Puliyel, R Srivastav, R Gupta, N Kumar, A Mathews.   

Abstract

An 11 year old male presented with headache, vomiting and weakness of right side of body. One day after admission he developed right focal seizures. He had 5 previous episodes of stroke, the first at 11 months age. His milestones were normal upto the first episode but subsequent mile stones were delayed. His serum and CSF lactic acids were raised. Muscle biopsy showed ragged red fibres on modified Gomori-trichrome staining. His EEG, CT scan and MRI were normal this time. The child improved spontaneously after 7 days. His recovery time progressively became shorter with each episode of stroke. Maximum time for recovery was noted during first episode and least in current episode. This is the first report of Melas syndrome in Indian literature.

Entities:  

Mesh:

Year:  1999        PMID: 10798118     DOI: 10.1007/bf02727181

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  21 in total

1.  MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy.

Authors:  J M Clark; M P Marks; E Adalsteinsson; D M Spielman; D Shuster; D Horoupian; G W Albers
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

2.  Creatine treatment in MELAS.

Authors:  L Hagenfeldt; U von Döbeln; G Solders; L Kaijser
Journal:  Muscle Nerve       Date:  1994-10       Impact factor: 3.217

3.  Accumulation of somatic nucleotide substitutions in mitochondrial DNA associated with the 3243 A-to-G tRNA(leu)(UUR) mutation in encephalomyopathy and cardiomyopathy.

Authors:  S A Kovalenko; M Tanaka; M Yoneda; A F Iakovlev; T Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1996-05-15       Impact factor: 3.575

4.  Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS.

Authors:  Y Ikejiri; E Mori; K Ishii; K Nishimoto; M Yasuda; M Sasaki
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

5.  MELAS of infantile onset: mitochondrial angiopathy or cytopathy?

Authors:  T Fujii; T Okuno; M Ito; K Mutoh; Y Horiguchi; H Tashiro; H Mikawa
Journal:  J Neurol Sci       Date:  1991-05       Impact factor: 3.181

6.  Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome.

Authors:  K Majamaa; H Rusanen; A M Remes; J Pyhtinen; I E Hassinen
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

7.  MELAS syndrome: correlation between clinical features and molecular genetic analysis.

Authors:  C W Liou; C C Huang; E C Chee; Y J Jong; J L Tsai; C Y Pang; H C Lee; Y H Wei
Journal:  Acta Neurol Scand       Date:  1994-11       Impact factor: 3.209

8.  Acute renal failure and the MELAS syndrome, a mitochondrial encephalomyopathy.

Authors:  F Hsieh; R Gohh; L Dworkin
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

9.  Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations.

Authors:  B Koo; L E Becker; S Chuang; F Merante; B H Robinson; D MacGregor; I Tein; V B Ho; D A McGreal; J R Wherrett
Journal:  Ann Neurol       Date:  1993-07       Impact factor: 10.422

10.  Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities ): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature.

Authors:  N Fukuhara; S Tokiguchi; K Shirakawa; T Tsubaki
Journal:  J Neurol Sci       Date:  1980-07       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.